| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |